期刊文献+

MTA3在肺癌细胞中调控细胞凋亡机制的研究 被引量:5

Regulation Mechanism of MTA3 in the Apoptosis of NSCLC Cells
暂未订购
导出
摘要 背景与目的肿瘤转移基因(metastasis associated gene,MTA)是一个肿瘤候选基因家族,主要包括MTA1、MTA2、MTA3,已有的研究证实在不同肿瘤中MTA3发挥着相反的作用,本研究旨在探讨MTA3在肺癌细胞中调控细胞凋亡方面的影响。方法应用Western blot方法和Real-time PCR方法检测肺癌细胞系A549和H157中MTA3的转染效率,流式细胞仪方法检测上调/下调MTA3后肺癌细胞凋亡情况,Western blot方法检测下调MTA3后凋亡相关基因的表达。结果在肺癌细胞系A549和H157中干扰MTA3后则促进细胞凋亡,同时引起凋亡相关蛋白Bax、ClevedCaspase-3、p-PARP表达上调及Bcl-2表达下调。结论 MTA3在肺癌细胞系A549和H157细胞中通过抑制凋亡相关基因的表达抑制细胞凋亡。 Background and objective Metastasis-associated protein 3 (MTA3) was originally found as a member of a small protein family (including MTA1, MTA2 and MTA3), and it has been proven that MTA3 had different roles in dif- ferent types of human cancers. The aim of this study is to explore the function of MTA3 to regulate the cell apoptosis in lung cancer. Methods Western blot and Real-time PCRwere used to detect the expression level of MTA3 after transfection in non- small cell lung cancer (NSCLC) ceIIs A549 and H157. Apoptosis analysis was used to detect the change of cell apoptosis with upregulated/downregulated of MTA3, and Western blot was used to detect the the expression of the protein related with apoptosis, while dowrtregulate the expression of MTA3 in NSCLC ceils A549 and H157. Results Downregulated of endogenous MTA3 could promote apoptosis in NSCLC cells, meanwhile, siMTA3 could upregulate the protein ofBAX, Cleved-Caspase-3, p-PARP, and dowmregulate the protein of Bcl-2. Conclusion The data we present here indicate that MTA3 suppress apoptosis ofA549 an H157 cells by inhibiting BAX, PARP expression.
出处 《中国肺癌杂志》 CAS CSCD 北大核心 2015年第10期610-615,共6页 Chinese Journal of Lung Cancer
基金 国家自然科学基金项目(No.81101493 No.81302612) 徐州医学院人才项目启动基金(No.D2014003)资助~~
关键词 肺肿瘤 肿瘤转移相关基因3 细胞凋亡 A549 H157 Lung neoplasms Metastasis associated gene 3 (MTA3) Apoptosis A549 H157
  • 相关文献

参考文献29

  • 1Jemal A, Siegel R, Xu J, et al. Cancer statistics. CA Cancer J Clin, 2010, 60(5): 277-300.
  • 2Minna JD, Roth JA, Gazdar AF. Focus on lung cancer. Cancer Cell, 2002, 1(1): 49-52.
  • 3Schiller JH, Harrington D, Belani CP, et al. Comparison of four chemother- apy regimens for advanced non-small-cell lung cancer. N EnglJ Med, 2002, 346(2): 92-98.
  • 4Idler IJ. The pathogenesis of cancer metastasis: the 'seed and soil' hypoth- esis revisited. Nat Key Cancer, 2003, 3(6): 453-458.
  • 5Hunter K, Welch DR, Liu ET. Genetic background is an important deter- minant of metastatic potential. Nat Genet, 2003, 34(1): 23-24.
  • 6Pencil SD, Toh Y, Nicolson GL. Candidate metastasis-associated genes of the rat 13762NF mammary adenocarcinoma. Breast Cancer Res Treat, 1993, Z5(2): 165-174.
  • 7Toh Y, Pencil SD, Nicolson GL. A novel candidate gene, mtal, differentially expressed in highly metastatic mammary adeno- carcinoma cell lines, cDNA cloning, expression, and protein analyses.J Biol Chem, 1994, 269(37): 229S8-22963.
  • 8Tong JK, Hassig CA, Schnitzler GR, et al. Chromatin deacetylation by an ATP-dependent nucleosome remodelling complex. Nature, 1998,395(6705); 917-921.
  • 9Xue Y, Wong J, Moreno GT, et al. NURD, a novel complex with both ATP- dependent chromatin-remodeling and histone deacetylase activities. Mol Cell, 1998, 2(6): 851-861.
  • 10Wade PA, Gegonne A, Jones PL, et al. Mi-2 complex couples DNA meth- ylation to chromatin remodelling and histone deaceWlation. Nat Genet, 1999, 23(1): 62-66.

同被引文献14

引证文献5

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部